Todd M. Wallach
Directeur Général chez Molecular Detection, Inc.
Profil
Todd M.
Wallach is currently the Chairman & Chief Executive Officer at Molecular Detection, Inc. and the President & Chief Executive Officer at Evogen, Inc. Previously, he held the position of Senior Director-Finance & Operations at Acuity Pharmaceuticals, Inc. from 2002 to 2007.
He also worked as a Principal at Aton Pharma, Inc. Mr. Wallach has a graduate degree from the University of Pennsylvania, an undergraduate degree from Purdue University, an MBA from Rider University, and another graduate degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Todd M. Wallach
Sociétés | Poste | Début |
---|---|---|
Molecular Detection, Inc.
Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Directeur Général | 05/10/2009 |
Evogen, Inc.
Evogen, Inc. Electronic Equipment/InstrumentsElectronic Technology Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics. Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation. | Directeur Général | - |
Anciens postes connus de Todd M. Wallach
Sociétés | Poste | Fin |
---|---|---|
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | Directeur Financier/CFO | 17/05/2007 |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | - |
Formation de Todd M. Wallach
Purdue University | Undergraduate Degree |
Rider University | Masters Business Admin |
The Wharton School of the University of Pennsylvania | Graduate Degree |
University of Pennsylvania | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | Commercial Services |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
Molecular Detection, Inc.
Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Health Technology |
Evogen, Inc.
Evogen, Inc. Electronic Equipment/InstrumentsElectronic Technology Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics. Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation. | Electronic Technology |